Palexia SR 50, 100, 150, 200, 250 mg prolonged-release tablets
Last Updated on eMC 15-Oct-2014 View document | Grunenthal Ltd Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15-Oct-2014 and displayed until Current
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
Updated on 03-Sep-2013 and displayed until 15-Oct-2014
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 2 - what you need to know - contraindications
- Change to section 3 - dose and frequency
- Change to section 4 - possible side effects
- Change to section 5 - how to store
- Change to section 6 - date of revision
- Improved presentation of PIL
- Removal of black triangle
Updated on 28-Mar-2011 and displayed until 03-Sep-2013
Reasons for adding or updating:
- New PIL for new product
Grunenthal Ltd
Units 1 and 2 Stokenchurch Business Park, Ibstone Road, Stokenchurch, Buckinghamshire, HP14 3FE, UK
+44 (0)870 351 8960
+44 (0)1494 486298
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue